New approach to N-substituted-1,2,3,6-tetrahydro-pyridine-4-carbaldehyde, a precursor for synthesizing Aricept®, isoguvacine, and deethylibophyllidine

Journal of the Chinese Chemical Society

Volumn 51, Issue 3, 2004, Pages 613-617

  Tsai, Min Ruei ^a   Sun, Pei Pei ^a   Chang, Meng Yang ^b   Changa, Nein Chen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY OF KAOHSIUNG   (Taiwan)

Author keywords

Alane reduction; Dehydrosulfonated; N substituted 4 formyl piperidine; Stepwise 3+3 annulation

Indexed keywords

EID: 33646370141     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.200400092     Document Type: Article

References (33)

1. (a) Hermans, B.; Van, D. P. Chem. Abstr. 1969, 70, 57585.
2. (b) Miwa, K.; Aoyama, T.; Shioiri, T. Synlett 1994, 2, 109.
3. (c) Chen, Y. L. EP 441517 A2 Chem. Abstr. 1991, 115, 232222.
4. (d) Abe, T.; Haga, T.; Negi, S.; Morita, Y.; Takayanagi, K.; Hamamura, K. Tetrahedron 2001, 57, 2701.
5. (a) Sugimoto, H.; Tsuchiya, Y.; Sugumi, H.; Higurashi, K.; Karibe, N.; Iimura, Y.; Sasai, A.; Kawakami, Y.; Nakamura, T.; Araki, S.; Yamanishi, Y.; Yamatsu, K. J. Med. Chem. 1990, 33, 1880.
6. (b) Sugimoto, H.; Tsuchiya, Y.; Sugumi, H.; Higurashi, K.; Karibe, N.; Iimura, Y.; Sasaki, A.; Araki, S., Yamanishi, Y.; Yamatsu, K. J. Med. Chem. 1992, 35, 4542.
7. (c) Sugimoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. J. Med. Chem. 1995, 38, 4821.
8. Shanklin, J. R. Jr.; Johnson, C. P. III; Proakis, A. G.; Barrett, R. J. J. Med. Chem. 1991, 34, 3011.
9. Ohshima, E.; Takami, H.; Harakawa, H.; Sato, H.; Obase, H.; Miki, I.; Ishii, A.; Ishii, H.; Sasaki, Y.; Ohmori, K.; Karasawa, A.; Kubo, K. J. Med. Chem. 1993, 36, 417.
10. (a) Nieduzak, T. R.; Carr, A. A. Tetrahedron Asymm. 1990, 1, 535.
11. (b) Carr, A. A.; Wiech, N. L. US patent 4, 783, 471, 1988 (Chem. Abstr., 1988, 700, 156281K).
12. (c) Lednicer, D. In The Organic Chemistry of Drug Synthesis; John Wiley & Sons, New York, 1999, 100.
13. (d) Dudley, M. W.; Wiech, N. L.; Miller, F. P.; Carr, A. A.; Cheng, H. C.; Roebel, L. E.; Doherty, N. S.; Yamamura, R. C.; Ursillo, R. C.; Palfreyman, M. G. Drug Development Res. 1988, 13, 29.
14. (e) Koerner, J. E.; Dage, R. C. FASEB J. 1989, 3, Al203, 5676.
15. (f) Li, T.; Dage, R.C. FASEB J. 1989, 3, A1204, 5677.
16. (g) Herndon, J. L.; Ismaiel, A.; Ingher, S. P.; Teitler, M.; Glennon, R. A. J. Med. Chem. 1992, 35, 4903.
17. (h) Ismaiel, A.; Arruda, K.; Teitler, M.; Glennon, R. A. J. Med. Chem. 1995, 38, 1196.
18. (i) Green, A. G.; Cross, A. J.; Goodwin, G. M. Psychopharmacology 1995, 119, 247.
19. (j) Mechan, A. O.; Esteban, B.; O'Shea, E.; Elliott, J. M.; Colado, M. I.; Green, A. R. Br. J. Pharmacol. 2002, 135, 170.
20. (a) Krogsgaard-Larsen, P.; Falch, E. J. Med. Chem. 1981, 24, 285.
21. (b) Cambell, A. L.; Pilipauskas, D. R.; Khanna, I. K.; Rhodes, R. A. Tetrahedron Lett. 1987, 28, 2331.
22. (c) Rohr, M.; Chayer, S.; Garrido, F.; Mann, A.; Taddei, M.; Wermuth, C.-G. Heterocycles. 1996, 43, 2131.
23. (d) Krogsgaard-Larsen, P.; Johnstone, G. A. R.; Lodge, D.; Curtis, D. R. Nature 1977, 268, 53.
24. (e) Krogsgaard-Larsen, P.; Hjeds, H.; Curtis, D. R.; Lodge, D.; Johnston, G. A. R. J. Neurochem. 1979, 32, 1717.
25. Sugimoto, H.; Tsuchiya, Y.; Higurashi, K.; Karibe, N.; Iimura, Y.; Sasaki, A.; Yamanishi, Y.; Ogura, H.; Araki, S. EP 296560 A2 Chem. Abstr. 1989, 110, 173102.
26. Bonjoch, J.; Ferandez, J.-C.; Valls, N. J. Org. Chem. 1998, 63, 7338.
27. (a) Chang, N. C.; Chang, M. Y.; Chang, B. R.; Tai, H. M. Tetrahedron Lett. 2000, 41, 10273.
28. (b) Hsu, R. T.; Cheng, L. M.; Chang, N. C.; Tai, H. M. J. Org. Chem. 2002, 67, 5044.
29. (c) Chang, M. Y.; Chen, S. T.; Chang, N. C. Tetrahedron 2002, 58, 5075.
30. (d) Chang, M. Y.; Chen, S. T.; Chang, N. C. Heterocycles 2002, 57, 2321.
31. Massiot, G.; Cherif, A. Bull. Soc. Chim. Fr. 1990, 127, 648.
32. Bonjoch, J.; Fernandex, J.-C.; Terricabras, D.; Valls, N. Tetrahedron 1997, 53, 9407.
33. Allen, M. S.; Gaskell, A. J.; Joule, J. A. J. Chem. Soc. 1971, 36, 2550.